Why The SAVE Act Matters Authored by Stu Cvrk via American Greatness , American self-governance rests on one indispensable foundation: that elections reflect the will of eligible citizens, counted accurately, administered transparently. Republicans and election integrity advocates argue that this foundation has been progressively undermined - not necessarily by a single grand conspiracy, but by a ...
Why The SAVE Act Matters Authored by Stu Cvrk via American Greatness , American self-governance rests on one indispensable foundation: that elections reflect the will of eligible citizens, counted accurately, administered transparently. Republicans and election integrity advocates argue that this foundation has been progressively undermined - not necessarily by a single grand conspiracy, but by a systemic pattern of loosened safeguards, dirty voter rolls, exploitable mail-ballot systems, and aggressive Democrat opposition to the audits and reforms that would resolve public doubt once and for all. The Safeguard American Voter Eligibility (SAVE) Act - which polls at roughly 80 percent public support - would require documentary proof of U.S. citizenship to register to vote in federal elections. To its advocates, it is the minimum logical response to documented vulnerabilities in the registration and voting system. To its opponents, it is voter suppression. The fight over that characterization is itself a revealing indicator of where the parties stand on the fundamental question: do you want to know, or don't you? And why! Let's examine the subject in some detail. Note: the below analysis was written from a Republican/election-integrity-advocate perspective. Where allegations are unconfirmed or contested, they are labeled as such. Part I: Confirmed And Documented Problems 1. Dirty Voter Rolls - A National Scandal The evidence that American voter rolls are riddled with ineligible registrations is not in dispute. The only dispute is over whether they should be fixed. The DOJ's Civil Rights Division, under Assistant AG Harmeet Dhillon, reviewed voter rolls from just 16 voluntarily cooperating Republican-leaning states and found tens of thousands of apparent noncitizens and hundreds of thousands of dead people still registered to vote. The administration subsequently sued 29 states - including blue-state heavyweights California and New York, and swing states Arizona and Geo...
FCPM III Services B.V. disclosed a new position in Damora Therapeutics (NASDAQ:DMRA) as of March 31, 2026, acquiring 2,441,000 shares for an estimated $65.63 million based on quarterly average pricing. According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, FCPM III Services B.V. initiated a new position in Damora Therapeutics by purchasing 2,441,000 shares. The estimate...
FCPM III Services B.V. disclosed a new position in Damora Therapeutics (NASDAQ:DMRA) as of March 31, 2026, acquiring 2,441,000 shares for an estimated $65.63 million based on quarterly average pricing. According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, FCPM III Services B.V. initiated a new position in Damora Therapeutics by purchasing 2,441,000 shares. The estimated value of this transaction was $65.63 million, calculated using the quarterly average price for the period from January 1 to March 31, 2026. The quarter-end position value was $63.22 million. Galecto, Inc. is a clinical-stage biotechnology company headquartered in Boston, MA. The company’s strategy centers on developing novel therapeutics that address unmet medical needs in oncology and fibrotic disorders. Galecto’s competitive edge lies in its proprietary small molecule inhibitors, positioning it as an innovator within the pharmaceutical development landscape. Continue reading
On May 14, 2026, GC Wealth Management RIA disclosed a new position in Porch Group (NASDAQ:PRCH) , acquiring 4,076,745 shares—an estimated $32.58 million trade based on quarterly average pricing. According to a SEC filing dated May 14, 2026, GC Wealth Management RIA initiated a new position in Porch Group by acquiring 4,076,745 shares during the first quarter. The estimated transaction value was $3...
On May 14, 2026, GC Wealth Management RIA disclosed a new position in Porch Group (NASDAQ:PRCH) , acquiring 4,076,745 shares—an estimated $32.58 million trade based on quarterly average pricing. According to a SEC filing dated May 14, 2026, GC Wealth Management RIA initiated a new position in Porch Group by acquiring 4,076,745 shares during the first quarter. The estimated transaction value was $32.58 million, calculated from the average share price over the quarter. At quarter’s end, the position was valued at $29.23 million, reflecting both the purchase and subsequent price movement. Porch Group, Inc. is a technology-driven company specializing in software and insurance solutions for the home services and property sector. With a multi-segment approach, the company leverages its platform to connect service providers, insurers, and consumers, aiming to streamline the homeownership journey. Its diversified revenue streams and integrated offerings position it to serve a broad customer base within the home services ecosystem. Continue reading
A view of the National Mall during at sunset in Washington, D.C., on Oct. 04, 2025. Mehmet Eser | AFP | Getty Images U.S. President Donald Trump said on Saturday he is considering canceling a planned series of concerts on Washington's National Mall commemorating the nation's 250th anniversary after a string of artists withdrew from the event, and replacing them with a speech and political-style ra...
A view of the National Mall during at sunset in Washington, D.C., on Oct. 04, 2025. Mehmet Eser | AFP | Getty Images U.S. President Donald Trump said on Saturday he is considering canceling a planned series of concerts on Washington's National Mall commemorating the nation's 250th anniversary after a string of artists withdrew from the event, and replacing them with a speech and political-style rally instead. The concerts were planned as part of the larger Great American State Fair, a 16-day event running from June 25 to July 10, 2026. Organizers said the fair, organized by the Freedom 250 group, would stretch along the National Mall from the U.S. Capitol to the Washington Monument, with concert stages, state pavilions, exhibits, rides, and other attractions spread across the Mall. But the musical lineup has been hit by a series of cancellations. On Friday, Bret Michaels, the lead singer of the rock band Poison, became the fifth performer to withdraw from the concerts, saying that the event was not the nonpartisan celebration that he thought it would be. Organizers have not publicly detailed the reasons for the departures, though the exits have raised questions about the viability of the event as originally envisioned. In a post on Truth Social on Saturday, Trump suggested the concert series may no longer be necessary if performers continue to back out. He floated the possibility of giving a speech on the National Mall instead, portraying himself as a more powerful draw than any musical act. "The fact is that I am, according to many, the Number One Attraction anywhere in the World," Trump wrote. He added that he gets "much larger audiences than Elvis in his prime" and "does so without a guitar." The president said he is "ordering my Representatives to look at the feasibility of doing an AMERICA IS BACK Rally." Freedom 250 is a public-private partnership created by the White House to coordinate celebrations of the United States' 250th anniversary in partnersh...
JHVEPhoto/iStock Editorial via Getty Images Incyte’s ( INCY ) immunotherapy Monjuvi, developed with Xencor ( XNCR ), will soon become a first-line option for a common type of lymphoma after late-stage trial data indicated on Saturday that the CD19-targeting monoclonal antibody with other drugs improved cancer-free survival by 25%. The analysis represented data from the company’s Phase 3 frontMIND ...
JHVEPhoto/iStock Editorial via Getty Images Incyte’s ( INCY ) immunotherapy Monjuvi, developed with Xencor ( XNCR ), will soon become a first-line option for a common type of lymphoma after late-stage trial data indicated on Saturday that the CD19-targeting monoclonal antibody with other drugs improved cancer-free survival by 25%. The analysis represented data from the company’s Phase 3 frontMIND trial, which enrolled newly diagnosed adults with high-risk diffuse large B-cell lymphoma, the most common form of non-Hodgkin lymphoma diagnosed among adults globally. Citing an interim analysis, Incyte ( INCY ) said that compared to R-CHOP, the standard of care, Monjuvi reduced the risk of disease progression or death by 25% in DLBCL when added to R-CHOP plus enalidomide, a multiple myeloma therapy marketed by J&J ( JNJ ) as Revlimid. “For years, R-CHOP has remained the standard first-line therapy for DLBCL,” remarked Georg Lenz, of University Hospital Münster and principal investigator of frontMIND. However, “nearly 40% of patients experience disease progression or relapse after initial treatment, underscoring the need for innovation,” Lenz added. The readout selected for a presentation at the ongoing ASCO presentation also indicated that patients well tolerated tafa-Len-R-CHOP with a tolerability profile consistent with safety findings of adding Tafa-Len to R-CHOP. In January, Incyte ( INCY ) said frontMIND met the main goal of progression-free survival. The company plans to conduct a final analysis of overall survival, a key secondary endpoint, as part of an additional follow-up. Incyte ( INCY ) expects existing frontMIND data could support global regulatory submissions seeking to add Monjuvi and enalidomide to R-CHOP to treat newly diagnosed DLBCL cases. More on Incyte, Xencor Incyte Corporation (INCY) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript Incyte Corporation (INCY) Presents at Bank of America Global Healthcare Conference 2026 Pre...
On May 15, 2026, Perry Creek Capital disclosed a purchase of 1,349,493 shares of Grindr (NYSE:GRND) , with an estimated transaction value of $15.91 million based on quarterly average pricing. According to a SEC filing dated May 15, 2026, Perry Creek Capital increased its stake in Grindr by 1,349,493 shares. The estimated value of this purchase, calculated using the average closing price for the fi...
On May 15, 2026, Perry Creek Capital disclosed a purchase of 1,349,493 shares of Grindr (NYSE:GRND) , with an estimated transaction value of $15.91 million based on quarterly average pricing. According to a SEC filing dated May 15, 2026, Perry Creek Capital increased its stake in Grindr by 1,349,493 shares. The estimated value of this purchase, calculated using the average closing price for the first quarter of 2026, was $15.91 million. The total value of the position at quarter-end reached $21.51 million, with the net position change reflecting both share accumulation and price movement over the quarter. Grindr Inc. operates a digital platform focused on the LGBTQ community and uses a dual revenue model consisting of subscriptions and advertising. Continue reading
YieldMax NVDA Option Income Strategy ETF (NYSEARCA:NVDY) sells NVIDIA’s upside each month and returns the premium to shareholders as income. That trade has produced a headline distribution yield north of 50% and capped how much of NVIDIA’s gains shareholders keep. The biggest risk is that the strategy works exactly as designed at the worst moment ... Why NVDY Shareholders Miss Half of NVIDIA’s Exp...
YieldMax NVDA Option Income Strategy ETF (NYSEARCA:NVDY) sells NVIDIA’s upside each month and returns the premium to shareholders as income. That trade has produced a headline distribution yield north of 50% and capped how much of NVIDIA’s gains shareholders keep. The biggest risk is that the strategy works exactly as designed at the worst moment ... Why NVDY Shareholders Miss Half of NVIDIA’s Explosive Moves in Strong Months
Zoom In Icon Arrows pointing outwards U.S. District Court Judge Eleanor Ross confirmation hearing, May 14, 2014, Senate Judiciary Committee - C-Span C-Span The Department of Justice on Friday asked Georgia federal judge Eleanor Ross to recuse herself from a pending case involving election records, citing media reports identifying Ross as the same judge who was disciplined for attending a victory p...
Zoom In Icon Arrows pointing outwards U.S. District Court Judge Eleanor Ross confirmation hearing, May 14, 2014, Senate Judiciary Committee - C-Span C-Span The Department of Justice on Friday asked Georgia federal judge Eleanor Ross to recuse herself from a pending case involving election records, citing media reports identifying Ross as the same judge who was disciplined for attending a victory party for a district attorney's campaign. The DOJ said that if Ross is that judge, "it creates the appearance of bias," because the victory party would have been in May 2024 for Fulton County DA Fani Willis , who prosecuted President Donald Trump for an alleged conspiracy to overturn the results of his 2020 election loss in Georgia to former President Joe Biden . "A judge who attended a party celebrating the election of a Democrat best known for prosecuting a Republican President for alleged election interference cannot then preside over a case concerning that President's efforts to ensure election integrity," the DOJ said in the motion for Ross' recusal, which was filed in U.S. District Court in Atlanta . The DOJ does not claim in the filing to have independently identified Ross, 58, as the judge who was disciplined, and CNBC has not confirmed that she is the judge. CNBC this week asked two of Ross's clerks to ask her to confirm to a reporter whether she is the judge disciplined by the Judicial Council. Ross did not respond to those queries. "The Eleventh Circuit's Judicial Council found that a 'Subject Judge' committed judicial misconduct by attending a partisan and political event," the filing noted. The Eleventh Judicial Circuit comprises federal courts in Georgia, Florida and Alabama. Ross has served as a federal judge since 2014, when she was nominated by then-President Barack Obama. The DOJ is suing Georgia Secretary of State Brad Raffensberger over his refusal to turn over election records to the Justice Department as part of a probe to ascertain the state's complian...
On May 14, 2026, Krensavage Asset Management disclosed it bought 241,245 shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) , an estimated $5.43 million trade based on quarterly average pricing. According to an SEC filing dated May 14, 2026, Krensavage Asset Management increased its stake in Ultragenyx Pharmaceutical by 241,245 shares during the first quarter. The estimated value of shares acquired...
On May 14, 2026, Krensavage Asset Management disclosed it bought 241,245 shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) , an estimated $5.43 million trade based on quarterly average pricing. According to an SEC filing dated May 14, 2026, Krensavage Asset Management increased its stake in Ultragenyx Pharmaceutical by 241,245 shares during the first quarter. The estimated value of shares acquired was $5.43 million, calculated using the average closing price for the period. The fund finished the quarter with 390,879 shares valued at $8.19 million. The position’s quarter-end value rose by $4.75 million, a figure that includes both trading activity and price changes. Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare and ultra-rare genetic diseases. The company combines a portfolio of approved products with a robust pipeline of clinical candidates, aiming to address significant unmet medical needs. Its strategy centers on leveraging scientific expertise and strategic partnerships to bring innovative treatments to underserved patient populations globally. Continue reading
US President Donald Trump said on Saturday that he was considering cancelling a planned series of concerts on Washington’s National Mall commemorating the nation’s 250th anniversary after a string of artists withdrew from the event, and replacing them with a speech and political-style rally instead. The concerts were planned as part of the larger Great American State Fair, a 16-day event runni...
US President Donald Trump said on Saturday that he was considering cancelling a planned series of concerts on Washington’s National Mall commemorating the nation’s 250th anniversary after a string of artists withdrew from the event, and replacing them with a speech and political-style rally instead. The concerts were planned as part of the larger Great American State Fair, a 16-day event running from June 25 to July 10, 2026. Organisers said the fair, organised by the Freedom 250 group,...
Sridhar Ramaswamy predicts that companies reliant on seat-based income will scramble to justify their premiums as employees use AI to accomplish an immense amount of work.
Sridhar Ramaswamy predicts that companies reliant on seat-based income will scramble to justify their premiums as employees use AI to accomplish an immense amount of work.
Retail investor Chris Camillo, host of the Dumb Money Live channel and a practitioner of what he calls “social arbitrage,” laid out a sweeping framework for the AI investment cycle on a recent episode of The Iced Coffee Hour with hosts Graham Stephan and Jack Selby. His core argument was simple. The first two phases of ... Investor Chris Camillo Predicts The ‘Last Easy Trade’ of the AI Supercycle ...
Retail investor Chris Camillo, host of the Dumb Money Live channel and a practitioner of what he calls “social arbitrage,” laid out a sweeping framework for the AI investment cycle on a recent episode of The Iced Coffee Hour with hosts Graham Stephan and Jack Selby. His core argument was simple. The first two phases of ... Investor Chris Camillo Predicts The ‘Last Easy Trade’ of the AI Supercycle Is About to Start